Finland, Jan. 28 -- Finland based Biogen Finland Oy has secured contract from HUS Group, the joint authority for Helsinki and Uusimaa for Pharmaceutical products - Acquisition of Nusinersene (Spinraza).. The value of the contract is worth 100000000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....